NICE misses golden opportunity to enhance access to innovative cancer drugs 07 Feb 2022 Cancer patients will miss out on exciting new treatments after NICE passed up a golden opportunity to ensure its evaluation methods support approval of the most innovative, potentially game-changing drugs. Find out more Show/Hide
Most innovative cancer drugs facing delays in reaching patients 29 Jan 2020 Despite increasing numbers of cancer drugs being licensed, an analysis has found that highly innovative drugs took longer to reach NHS patients than more conventional treatments. Find out more Show/Hide
UK cancer treatment ‘revolution’ as survey finds third of patients receiving modern precision treatments 16 Jul 2019 Over one-third of surviving cancer patients have received state-of-the-art targeted drug treatment or immunotherapy, reveals a new survey highlighting the ‘revolution’ in cancer treatment over the last decade. Find out more Show/Hide